ESR1 and breast cancer: Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer (BC), morphologically characterized by the lack of expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), accounting for 10%–15% of BC.